A Private sector incentives to participate in research partnerships can be grouped roughly into two categories: cost-economizing incentives and strategic incentives. This paper summarizes the argument in two streams of thought that are often identified with these two sides: the transaction-cost/incomplete contracts approach and the strategic management approach. The paper recounts business motives to engage in research partnerships in each and points out that differentiating between more traditional economic perspectives (transaction costs, incomplete contracts) and strategic management/organizational theory perspectives (strategic networks, resource-dependent view, dynamic capabilities, knowledge-based view, organizational learning, options approach) may not be as sharp as one might suppose at first. The complementary nature of these perspectives should be encouraging for theoreticians looking for a more integrated model of collaboration.

The Internet of Things (IoT), sometimes referred to as the Internet of Objects, will change everything-including ourselves. This may seem like a bold statement, but consider the impact the Internet already has had on education, communication, business, science, government, and humanity. Clearly, the Internet is one of the most important and powerful creations in all of human history. Now consider that IoT represents the next evolution of the Internet, taking a huge leap in its ability to gather, analyze, and distribute data that we can turn into information, knowledge, and, ultimately, wisdom. In this context, IoT becomes immensely important. Already, IoT projects are under way that promise to close the gap between poor and rich, improve distribution of the world's resources to those who need them most, and help us understand our planet so we can be more proactive and less reactive. Even so, several barriers exist that threaten to slow IoT development, including the transition to IPv6, having a common set of standards, and developing energy sources for millions-even billions-of minute sensors. However, as businesses, governments, standards bodies, and academia work together to solve these challenges, IoT will continue to progress. The goal of this paper, therefore, is to educate you in plain and simple terms so you can be well versed in IoT and understand its potential to change everything we know to be true today.

No abstract

Biotechnology Industry Organization, corporate social responsibility, extraordinary pricing, National Organization for Rare Disorders, Inc., orphan drugs, patient access, Pharmaceutical Research and Manufacturers of America, pharmaceutical industry, pharmaceutical pricing, reputation,

No abstract